| 注册
首页|期刊导航|医药导报|抗精神病药物相关性帕金森综合征的研究进展

抗精神病药物相关性帕金森综合征的研究进展

刘丽萍 海鑫

医药导报2025,Vol.44Issue(10):1549-1555,7.
医药导报2025,Vol.44Issue(10):1549-1555,7.DOI:10.3870/j.issn.1004-0781.2025.10.004

抗精神病药物相关性帕金森综合征的研究进展

Research Progress on Antipsychotic Drugs Associated Parkinson's Syndrome

刘丽萍 1海鑫2

作者信息

  • 1. 哈尔滨市第一专科医院科教科,哈尔滨 150056
  • 2. 哈尔滨医科大学附属第一医院药学部,哈尔滨 150001
  • 折叠

摘要

Abstract

Antipsychotic drug associated Parkinson's syndrome(AAP)is a drug-induced disease that significantly affects patient's choice of clinical treatment options and treatment adherence.With the development of new drugs,the incidence of AAP is continuously increasing,and it is difficult to distinguish it from primary Parkinson's syndrome.This article outlines the epidemiological features,risk factors,pathogenesis,and advances in clinical diagnosis and treatment of AAP,with the goal of enhancing clinical recognition of AAP,developing effective prevention and treatment strategies,and reducing its incidence.

关键词

抗精神病药物/帕金森综合征/流行病学

Key words

Antipsychotic drug/Parkinson's syndrome/Epidemiology

分类

医药卫生

引用本文复制引用

刘丽萍,海鑫..抗精神病药物相关性帕金森综合征的研究进展[J].医药导报,2025,44(10):1549-1555,7.

基金项目

黑龙江省卫生健康委科研课题(20230303090154、20221313051086). (20230303090154、20221313051086)

医药导报

OA北大核心

1004-0781

访问量1
|
下载量0
段落导航相关论文